Drugs / Lutein

Trials 10 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT06270680 Aug → Nov 2024 brain injury, carotenemia Penn State University Completed No outcome recorded
Phase 11 trial
Phase 1 NCT00121589 Jul 2005 → Aug 2007 macular degeneration National Eye Institute (NEI) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00029289 Apr 2001 → Oct 2002 retinitis pigmentosa National Center for Complementary and Integrative Health (NCCIH) Completed No outcome recorded
Phase 23 trials
Phase 2 NCT03750968 Sep 2019 → Jan 2022 nutritional deficiency disease, pregnancy disorder Paul S. Bernstein Completed No outcome recorded
Phase 2 NCT02062034 Feb 2011 → Nov 2013 diabetic retinopathy, type 2 diabetes mellitus University of Guadalajara Completed No outcome recorded
Phase 2 NCT00006202 Sep 2000 → Aug 2003 macular degeneration National Eye Institute (NEI) Completed No outcome recorded
Phase 32 trials
Phase 3 NCT03702374 Sep 2018 → Nov 2020 diabetic retinopathy University of Guadalajara Completed No outcome recorded
Phase 3 NCT00346333 Jul 2003 → Dec 2008 retinitis pigmentosa National Eye Institute (NEI) Completed No outcome recorded
Phase 41 trial
Phase 4 NCT00449917 Sep 2006 → Jul 2007 PiLeJe Completed No outcome recorded
Phase not applicable1 trial
NCT03340103 Oct 2018 → Oct 2019 Sooft Italia Withdrawn No outcome recorded
Also used as a comparator or background therapy in 6 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/23 trials
Phase 1/2 NCT03959592 Comparator Aug 2019 → Nov 2021 glaucoma Felipe Medeiros, MD Terminated No outcome recorded
Phase 1/2 NCT01056094 Comparator Apr 2010 → Jul 2012 Peking University Unknown No outcome recorded
Phase 1/2 NCT01048476 Comparator Sep 2009 → Apr 2012 age-related macular degeneration Peking University Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT04071977 Comparator Mar 2020 → Oct 2021 diabetes mellitus, diabetic retinopathy University of Guadalajara Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00345176 Comparator Sep 2006 → Oct 2012 age-related macular degeneration, cataract National Eye Institute (NEI) Completed No outcome recorded
Phase not applicable1 trial
NCT00914576 Comparator Apr 2011 → Jul 2013 Medical University of Vienna Completed No outcome recorded

Evidence & citations 24 cited values

Every value below carries the sentence it was read from. 17 sources stand behind the page.

FieldValueCited text
Known as Lutein “It consists in a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1mg), vitamin C (L-ascorbic acid 180mg), vitamin E (DL-alpha tocopherol 30mg), zinc (zinc oxide...” NCT03702374
15

“(1 mg copper, 20 mg zinc, 180 mg vitamin C, 30 mg vitamin E, 1 mg zeaxanthin, 4 mg astaxanthin, 10 mg lutein) daily of oral, all of them in one Tablet for 24 weeks” NCT02062034

LUTEIN ofta 0,5 gocce, containing a solution of 5% Lutein and 2,5% Zeaxanthin with excipients (Corn starch, glucose, potassium sorbate, xanthan gum, citric acid)” NCT03340103

“Each dose will consist of one supplement capsule containing 10 mg lutein, 2 mg zeaxanthin, 10 mg mesozeaxanthin, 50mg EPA, 250mg DHA.” NCT06270680

“containing: Lutein 12mg, Vitamin C 300mg, Zinc 10mg, Ginko Biloba 10mg, Flavonoids 25mg, Fish oil 300mg” NCT00914576

“Softgel active ingredients: Lutein 10 mg and Zeaxanthin 2 mg in safflower oil” NCT03750968

“tablet with lutein (10 mg)” NCT04071977

NCT00029289

NCT00449917

NCT00346333

NCT03959592

NCT00006202

NCT00345176

NCT00121589

NCT01056094

NCT01048476

Known as All-trans-lutein ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as All-trans-xanthophyll ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Bo-xan ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as E 161 ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as E 161b ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as E-161B(I) ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Floraglo ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Floraglo lutein ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as INS NO.161B(I) ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as INS-161B(I) ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Leutein ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Lutein a ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Lutein from tagetes erecta ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as NSC-59193 ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Oro glo 7 ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Os 24 ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Trans-lutein ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Vegetable lutein ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Vegetable luteol ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Xanthophyll ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Known as Xantofyl ChEMBL registry synonym — accepted as the source's own label CHEMBL173929
Modality Other / unclassified “dietary supplement” NCT00449917
Route Oral “varying doses of oral supplementation of lutein” NCT00006202